{"entity":{"type":"insider","cik":"0001841537","url":"/insider/0001841537","json_url":"/insider/0001841537.json","name":"OrbiMed Advisors III Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":4,"first":"2021-02-09","last":"2024-07-17","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Advisors III Ltd","source":"filing","n_filings":4,"first_seen":"2021-02-09","last_seen":"2024-07-17"}],"transactions":[{"id":2942890,"accession":"0000947871-24-000627","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-24-000627","line_url":"/filing/0000947871-24-000627","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Advisors III Ltd; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Asia GP III, L.P.","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5188.0,"shares_display":"5,188","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":51880.0,"total_display":"51,880.00","total_whole":"51,880","shares_owned_after":4839412.0,"shares_owned_after_display":"4,839,412","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-17","scope":"insider","n_lines":3},{"id":2942876,"accession":"0000947871-24-000627","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000627","line_url":"/filing/0000947871-24-000627","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Advisors III Ltd; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Asia GP III, L.P.","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50976.0,"shares_display":"50,976","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":509760.0,"total_display":"509,760.00","total_whole":"509,760","shares_owned_after":4843421.0,"shares_owned_after_display":"4,843,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-17","scope":"insider","n_lines":3},{"id":6206597,"accession":"0000947871-22-001260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-22-001260","line_url":"/filing/0000947871-22-001260#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Advisors III Ltd; OrbiMed Asia GP III, L.P.; OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Advisors III Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":137931.0,"shares_display":"137,931","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":999999.75,"total_display":"999,999.75","total_whole":"1,000,000","shares_owned_after":4882854.0,"shares_owned_after_display":"4,882,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-23","filed_date":"2022-12-28","scope":"insider"},{"id":6921430,"accession":"0000947871-22-000911","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-22-000911","line_url":"/filing/0000947871-22-000911","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Advisors III Ltd; OrbiMed Genesis GP LLC; OrbiMed Asia GP III, L.P.; ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"OrbiMed Advisors III Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3690000.0,"shares_display":"3,690,000","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":8929800.0,"total_display":"8,929,800.00","total_whole":"8,929,800","shares_owned_after":4744923.0,"shares_owned_after_display":"4,744,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider","n_lines":3},{"id":4146720,"accession":"0001567619-21-002592","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-002592","line_url":"/filing/0001567619-21-002592","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Advisors III Ltd; OrbiMed Capital GP VII LLC; OrbiMed Asia GP III, L.P.","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":475000.0,"shares_display":"475,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":8075000.0,"total_display":"8,075,000.00","total_whole":"8,075,000","shares_owned_after":2274723.0,"shares_owned_after_display":"2,274,723","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831363","name":"Terns Pharmaceuticals, Inc.","url":"/issuer/0001831363","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2021-02-09","last_seen":"2024-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001841537","retrieved_at":"2026-08-25T09:27:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}